Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication for hyperkinetic children.

J S Werry

    Drugs
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Hyperkinetic syndrome, characterized by hyperactivity and attention deficits, is diagnosed clinically. Stimulant medications like dextroamphetamine and methylphenidate are most effective for managing this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Third-Party Payment for Medical Services.

    Canadian Medical Association journal·2010
    Same author

    Letters to the Journal.

    Canadian Medical Association journal·2010
    Same author

    Public Relations.

    Canadian Medical Association journal·2010
    Same author

    Public Relations.

    Canadian Medical Association journal·2010
    Same author

    Saskatchewan Doctors' Opinions of "Medicare": A Questionnaire Survey.

    Canadian Medical Association journal·2010
    Same author

    School refusal and emotional lability in a 6-year-old boy.

    Journal of developmental and behavioral pediatrics : JDBP·2001
    Same journal

    The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

    Drugs·2026
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    Same journal

    Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

    Drugs·2026
    See all related articles

    Area of Science:

    • Neuroscience and Behavioral Science
    • Pediatric Neurology and Psychiatry

    Background:

    • Hyperkinetic syndrome presents as a complex of symptoms including hyperactivity, short attention span, distractibility, and impulsivity.
    • Current diagnostic approaches rely heavily on clinical judgment due to the lack of objective definitions for core symptoms.
    • Behavioral and learning difficulties are often associated with this syndrome.

    Purpose of the Study:

    • To review the diagnostic challenges and therapeutic strategies for hyperkinetic syndrome.
    • To evaluate the role and efficacy of pharmacological interventions in managing hyperkinetic syndrome.
    • To identify the most effective medications for treating the symptoms of hyperactivity and attention deficits.

    Main Methods:

    • Review of existing literature on hyperkinetic syndrome diagnosis and treatment.

    Related Experiment Videos

  • Analysis of the clinical utility and risks associated with various psychotropic medications.
  • Assessment of stimulant medications, antipsychotics, tricyclic antidepressants, and pemoline.

    • Main Results:

    • Stimulant drugs, specifically dextroamphetamine and methylphenidate, are identified as the most effective treatments.
    • Antipsychotic medications may offer some benefit but carry risks of impairing cognitive functions.
    • Tricyclic antidepressants and pemoline show potential value, though less consistently than stimulants.

    Conclusions:

    • The management of hyperkinetic syndrome requires careful clinical assessment and skilled medical supervision.
    • Pharmacological treatment, particularly with stimulant medications, plays a significant role in managing core symptoms.
    • The choice of medication involves balancing therapeutic benefits against potential side effects and risks.